N-[3-(1H-imidazol-4-ylmethyl)phenyl]ethanesulfonamide (ABT-866, 1),(1) a novel alpha(1)-adrenoceptor ligand with an enhanced in vitro and in vivo profile relative to phenylpropanolamine and midodrine.

MLA

Altenbach, Robert J., et al. “N-[3-(1H-Imidazol-4-Ylmethyl)Phenyl]Ethanesulfonamide (ABT-866, 1),(1) a Novel Alpha(1)-Adrenoceptor Ligand with an Enhanced in Vitro and in Vivo Profile Relative to Phenylpropanolamine and Midodrine.” Journal of Medicinal Chemistry, vol. 45, no. 20, Sept. 2002, pp. 4395–97. EBSCOhost, https://doi.org/10.1021/jm025550h.

APA

Altenbach, R. J., Khilevich, A., Meyer, M. D., Buckner, S. A., Milicic, I., Daza, A. V., Brune, M. E., O’Neill, A. B., Gauvin, D. M., Cain, J. C., Nakane, M., Holladay, M. W., Williams, M., Brioni, J. D., & Sullivan, J. P. (2002). N-[3-(1H-imidazol-4-ylmethyl)phenyl]ethanesulfonamide (ABT-866, 1),(1) a novel alpha(1)-adrenoceptor ligand with an enhanced in vitro and in vivo profile relative to phenylpropanolamine and midodrine. Journal of Medicinal Chemistry, 45(20), 4395–4397. https://doi.org/10.1021/jm025550h

Chicago

Altenbach, Robert J, Albert Khilevich, Michael D Meyer, Steven A Buckner, Ivan Milicic, Anthony V Daza, Michael E Brune, et al. 2002. “N-[3-(1H-Imidazol-4-Ylmethyl)Phenyl]Ethanesulfonamide (ABT-866, 1),(1) a Novel Alpha(1)-Adrenoceptor Ligand with an Enhanced in Vitro and in Vivo Profile Relative to Phenylpropanolamine and Midodrine.” Journal of Medicinal Chemistry 45 (20): 4395–97. doi:10.1021/jm025550h.